Publikationen von 0000-0001-9836-0933
(ORCID: 0000-0001-9836-0933)

Kreft, Sophia, Glutsch, Valerie, Zaremba, Anne, Schummer, Patrick , Mohr, Peter, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Sachse, Michael Max, Meiss, Frank, Forschner, Andrea, Haferkamp, Sebastian, Welzel, Julia, Terheyden, Patrick, Herbst, Rudolf, Utikal, Jochen, Kaatz, Martin, Weishaupt, Carsten, Kreuter, Alexander, Debus, Dirk, Duecker, Pia, Sindrilaru, Anca, Löffler, Harald, Schley, Gaston, Weichenthal, Michael, Schadendorf, Dirk, Ugurel, Selma, Gesierich, Anja und Schilling, Bastian (2022) MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. European Journal of Cancer 167, S. 32-41. Volltext nicht vorhanden.

Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy , Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick , Sirokay, Judith , Kiecker, Felix, Owen, Carina N., Fleischer, Maria I., Cann, Christopher, Kähler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis , Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pföhler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina V. , Stang, Andreas, Schadendorf, Dirk und Zimmer, Lisa (2021) Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. European Journal of Cancer 148, S. 61-75. Volltext nicht vorhanden.